A financial analysis of Solvay. Solvay engages in the chemical and plastic businesses worldwide.

1. A financial analysis

2. Overview
1. Key figures
2. Deep analysis
3. Conclusion

3. Key figures
• 12.4 billion euros in net sales in 2012
• Listed on the NYSE Euronext stock exchange in Brussels &
Paris
• Main businesses consist out Chemicals, Plastics and Rhodia

4. Overall trend
• Positive trend
• April 2012 –’13
• Stock increased by +/- 30 euros

5. Deep analysis
Midsummer stock drop
• Share drops to 72,03 euros
• Build new factory in China

6. Deep analysis
Recovery
Investments:
• Contract with battery firm (Bolloré)
• Invest 10 million in Salindres
• Joint venture: Russpav
• 70% higher productivity rate in India

7. Deep analysis
Sharp rise
• Restructure of soda-activities
• Takeover of Shunshield Chemicals
 A leap of +/-28 euros
(November – mid-February)

8. Deep analysis
Decline
From 118,25 to 105,60 euros
Mid-February until end of March
• Build new silica factory in Poland
• Publication of the annual results

9. Dividend

10. Conclusion
• Overall positive trend
• Recommendation: don’t buy and/or hold
Forecast
Remain stable
Current ratio 2,40
PEG ratio -2,65
P/B ratio 1,34